![]() | Arthi ReddyFrom the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University ... |
KOL Resume for Arthi Reddy
Year | |
---|---|
2015 | From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical |
2013 | Nyu School of Medicine |
Arthi Reddy: Influence Statistics
Concept | World rank |
---|---|
medications belimumab | #13 |
soluble lymphocyte stimulator | #23 |
belimumab benlysta | #23 |
soluble blymphocyte stimulator | #41 |
benlysta | #41 |
initiation belimumab | #42 |
onset antibodies monoclonal | #96 |
efficacy belimumab | #98 |
Open the FULL List in Excel | |
Prominent publications by Arthi Reddy
Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.
[ PUBLICATION ]
OBJECTIVE: To evaluate the use and efficacy of belimumab in academic practices. Belimumab is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been approved for the treatment of adults with systemic lupus erythematosus (SLE).
METHODS: Invitations to participate and complete a 1-page questionnaire for each patient prescribed belimumab were sent to 16 physicians experienced in SLE phase III clinical trials. The outcome was defined as the physician's ...
Known for Lupus Erythematosus | Patients Sle | 6 Months | Onset Antibodies | Efficacy Belimumab |
Key People For Lupus Erythematosus
Arthi Reddy:Expert Impact
Concepts for whichArthi Reddyhas direct influence:Lupus erythematosus, Systemic lupus erythematosus, Efficacy belimumab, Patients sle, Belimumab benlysta, Belimumab sle, Systemic lupus, Onset antibodies.
Arthi Reddy:KOL impact
Concepts related to the work of other authors for whichfor which Arthi Reddy has influence:Systemic lupus erythematosus, Belimumab patients, Treatment sle, Lupus nephritis, Maintenance therapy, Biological therapies, Damage progression.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |